Abstract

Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2019 - Volume 23, Number 4

Page(s): 315

Download in electronic PDF format for $75
  • Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP Page 1

Abstract

A formulation for preparing Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • candesartan cilexetil
  • hypertension
  • high blood pressure
  • antihypertensive agent
  • racemic mixture

Related Categories

  • FORMULATIONS
  • CARDIOLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2019
Pg. 315
Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 232
Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2017
Pg. 147
Candesartan Cilexetil 8 mg Liquid-Filled Capsules
Author(s): Allen Loyd V Jr
May/Jun 2022
Pg. 234
Candesartan Cilexitil 1 mg/mL Syrup
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jan/Feb 2001
Pg. 65-67
Oral Liquid Vehicles, Featured Excipient:
Author(s): Allen Loyd V Jr
Sep/Oct 2019
Pg. 412
Valsartan 4 mg/mL in Vehicle for Oral Solution USP
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 139
Valsartan 4 mg/mL in Syrup NF
Author(s): Allen Loyd V Jr
Mar/Apr 2003
Pg. 145-148
Featured Excipient: Plasticizers
Author(s): Allen Loyd V Jr
Jan/Feb 2003
Pg. 48-50
Featured Excipient: Flavor Enhancing Agents
Author(s): Allen Loyd V Jr
Nov/Dec 2005
Pg. 456-461
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Author(s): Fonseca Simonne C
Mar/Apr 2015
Pg. 152-160
Transdermal Delivery of Nisoldipine: Refinement of Vehicles
Author(s): El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A
Mar/Apr 2005
Pg. 117-119
Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure
Author(s): Harrington Catherine A, Cauffield Jacintha
May/Jun 2005
Pg. 201-205
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
Author(s): Harrington Catherine A, Cauffield Jacintha
Jan/Feb 2021
Pg. 43
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2008
Pg. 392-397
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Author(s): Mixon William, Helms Scott R
Jan/Feb 2021
Pg. 44
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 142
Amlodipine 1-mg/mL in Oral Mix Suspension
Author(s): Allen Loyd V Jr